Loading…

Hematopoietic stem cell transplantation in Algeria

Algeria is a country of 40.4 million inhabitants and half of which is under 30years. In Algeria, Health-care insurance covered, 90% of the population. Health care is free and it is supported by the Ministry of Health. 16 university hospitals exist in Algeria and only two (Algiers and Oran) practicin...

Full description

Saved in:
Bibliographic Details
Published in:Hematology/oncology and stem cell therapy 2017-12, Vol.10 (4), p.311-314
Main Authors: Bekadja, Mohamed Amine, Brahimi, Mohamed, Osmani, Soufi, Yafour, Nabil, Krim, Amina, Serradj, Faiza, Talhi, Souad, Amani, Kamila, Bouhass, Rachid Amar
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3239-b012da9b1233048b4fbdbc5a2dac9953c1d566b6f3cc62c7cb9d4a003072ead3
cites cdi_FETCH-LOGICAL-c3239-b012da9b1233048b4fbdbc5a2dac9953c1d566b6f3cc62c7cb9d4a003072ead3
container_end_page 314
container_issue 4
container_start_page 311
container_title Hematology/oncology and stem cell therapy
container_volume 10
creator Bekadja, Mohamed Amine
Brahimi, Mohamed
Osmani, Soufi
Yafour, Nabil
Krim, Amina
Serradj, Faiza
Talhi, Souad
Amani, Kamila
Bouhass, Rachid Amar
description Algeria is a country of 40.4 million inhabitants and half of which is under 30years. In Algeria, Health-care insurance covered, 90% of the population. Health care is free and it is supported by the Ministry of Health. 16 university hospitals exist in Algeria and only two (Algiers and Oran) practicing bone marrow transplant. Adult hematologic malignancies account for 10% (about 4000 new cases/year) of the malignancy affecting in most cases young patients under 65years of age. In 2016, 270 transplants were performed in total (Algiers+Oran), including 149 allografts (related donor transplants: 99%) and 121 autografts. 98% of transplants are done in adults and only 2% in children with cord blood transplants. In summary for the two transplant centers, the predominant types of transplantation performed are allogeneic transplant in 55% and autologous transplant in 45%. The particularity of EHU1st November in Oran, is the use of non-cryopreserved stem cells. Stem cell was mobilized using G-CSF alone and the grafts were kept in a conventional blood bank refrigerator at +4°C until reinfusion on day 0. The outcome with non-cryopreserved stem cells are the same as those with cryopreserved stem cells and we conclude that autologous transplant with non cryopreserved hematopoietic stem cells (HSC) is a simple, effective and safe method and the cryopreservation is not necessary in our work conditions in developing countries. The projects are achieving the autograft in all University Hospitals with non cryopreserved HSC, achieving a center allograft in the east of the country and the development of bone marrow transplantation in children. Currently in Algeria, the number of transplantation is insufficient and the development of new transplant centers is essential. In the future, we hope to implement the National Society of Bone Marrow transplant and also the National recipient registry and Donor registry in Algeria.
doi_str_mv 10.1016/j.hemonc.2017.05.019
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1920203795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1658387617300572</els_id><sourcerecordid>1920203795</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3239-b012da9b1233048b4fbdbc5a2dac9953c1d566b6f3cc62c7cb9d4a003072ead3</originalsourceid><addsrcrecordid>eNp9kDtPwzAQxz2AaCl8A4QysiT4kdjJglRVQJEqsXS3_LiAqyQOtovEtydVgJHppNP_cfdD6IbggmDC7w_FO_R-MAXFRBS4KjBpztCS8KrOWS34Al3GeMCYMyGqC7SgtSCkrOgS0S30KvnRO0jOZDFBnxnouiwFNcSxU0NSyfkhc0O27t4gOHWFzlvVRbj-mSu0f3rcb7b57vX5ZbPe5YZR1uQaE2pVowllDJe1LltttanUtDRNUzFDbMW55i0zhlMjjG5sqTBmWFBQlq3Q3Rw7Bv9xhJhk7-LpNDWAP0ZJGoopZmKKWqFylprgYwzQyjG4XoUvSbA8AZIHOQOSJ0ASV3ICNNlufxqOugf7Z_qlMwkeZgFMb346CDIaB4MB6wKYJK13_zd8A5l7eqU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1920203795</pqid></control><display><type>article</type><title>Hematopoietic stem cell transplantation in Algeria</title><source>ScienceDirect - Connect here FIRST to enable access</source><creator>Bekadja, Mohamed Amine ; Brahimi, Mohamed ; Osmani, Soufi ; Yafour, Nabil ; Krim, Amina ; Serradj, Faiza ; Talhi, Souad ; Amani, Kamila ; Bouhass, Rachid Amar</creator><creatorcontrib>Bekadja, Mohamed Amine ; Brahimi, Mohamed ; Osmani, Soufi ; Yafour, Nabil ; Krim, Amina ; Serradj, Faiza ; Talhi, Souad ; Amani, Kamila ; Bouhass, Rachid Amar</creatorcontrib><description>Algeria is a country of 40.4 million inhabitants and half of which is under 30years. In Algeria, Health-care insurance covered, 90% of the population. Health care is free and it is supported by the Ministry of Health. 16 university hospitals exist in Algeria and only two (Algiers and Oran) practicing bone marrow transplant. Adult hematologic malignancies account for 10% (about 4000 new cases/year) of the malignancy affecting in most cases young patients under 65years of age. In 2016, 270 transplants were performed in total (Algiers+Oran), including 149 allografts (related donor transplants: 99%) and 121 autografts. 98% of transplants are done in adults and only 2% in children with cord blood transplants. In summary for the two transplant centers, the predominant types of transplantation performed are allogeneic transplant in 55% and autologous transplant in 45%. The particularity of EHU1st November in Oran, is the use of non-cryopreserved stem cells. Stem cell was mobilized using G-CSF alone and the grafts were kept in a conventional blood bank refrigerator at +4°C until reinfusion on day 0. The outcome with non-cryopreserved stem cells are the same as those with cryopreserved stem cells and we conclude that autologous transplant with non cryopreserved hematopoietic stem cells (HSC) is a simple, effective and safe method and the cryopreservation is not necessary in our work conditions in developing countries. The projects are achieving the autograft in all University Hospitals with non cryopreserved HSC, achieving a center allograft in the east of the country and the development of bone marrow transplantation in children. Currently in Algeria, the number of transplantation is insufficient and the development of new transplant centers is essential. In the future, we hope to implement the National Society of Bone Marrow transplant and also the National recipient registry and Donor registry in Algeria.</description><identifier>ISSN: 1658-3876</identifier><identifier>DOI: 10.1016/j.hemonc.2017.05.019</identifier><identifier>PMID: 28711452</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><ispartof>Hematology/oncology and stem cell therapy, 2017-12, Vol.10 (4), p.311-314</ispartof><rights>2017 King Faisal Specialist Hospital &amp; Research Centre</rights><rights>Copyright © 2017 King Faisal Specialist Hospital &amp; Research Centre. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3239-b012da9b1233048b4fbdbc5a2dac9953c1d566b6f3cc62c7cb9d4a003072ead3</citedby><cites>FETCH-LOGICAL-c3239-b012da9b1233048b4fbdbc5a2dac9953c1d566b6f3cc62c7cb9d4a003072ead3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1658387617300572$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27901,27902,45756</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28711452$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bekadja, Mohamed Amine</creatorcontrib><creatorcontrib>Brahimi, Mohamed</creatorcontrib><creatorcontrib>Osmani, Soufi</creatorcontrib><creatorcontrib>Yafour, Nabil</creatorcontrib><creatorcontrib>Krim, Amina</creatorcontrib><creatorcontrib>Serradj, Faiza</creatorcontrib><creatorcontrib>Talhi, Souad</creatorcontrib><creatorcontrib>Amani, Kamila</creatorcontrib><creatorcontrib>Bouhass, Rachid Amar</creatorcontrib><title>Hematopoietic stem cell transplantation in Algeria</title><title>Hematology/oncology and stem cell therapy</title><addtitle>Hematol Oncol Stem Cell Ther</addtitle><description>Algeria is a country of 40.4 million inhabitants and half of which is under 30years. In Algeria, Health-care insurance covered, 90% of the population. Health care is free and it is supported by the Ministry of Health. 16 university hospitals exist in Algeria and only two (Algiers and Oran) practicing bone marrow transplant. Adult hematologic malignancies account for 10% (about 4000 new cases/year) of the malignancy affecting in most cases young patients under 65years of age. In 2016, 270 transplants were performed in total (Algiers+Oran), including 149 allografts (related donor transplants: 99%) and 121 autografts. 98% of transplants are done in adults and only 2% in children with cord blood transplants. In summary for the two transplant centers, the predominant types of transplantation performed are allogeneic transplant in 55% and autologous transplant in 45%. The particularity of EHU1st November in Oran, is the use of non-cryopreserved stem cells. Stem cell was mobilized using G-CSF alone and the grafts were kept in a conventional blood bank refrigerator at +4°C until reinfusion on day 0. The outcome with non-cryopreserved stem cells are the same as those with cryopreserved stem cells and we conclude that autologous transplant with non cryopreserved hematopoietic stem cells (HSC) is a simple, effective and safe method and the cryopreservation is not necessary in our work conditions in developing countries. The projects are achieving the autograft in all University Hospitals with non cryopreserved HSC, achieving a center allograft in the east of the country and the development of bone marrow transplantation in children. Currently in Algeria, the number of transplantation is insufficient and the development of new transplant centers is essential. In the future, we hope to implement the National Society of Bone Marrow transplant and also the National recipient registry and Donor registry in Algeria.</description><issn>1658-3876</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kDtPwzAQxz2AaCl8A4QysiT4kdjJglRVQJEqsXS3_LiAqyQOtovEtydVgJHppNP_cfdD6IbggmDC7w_FO_R-MAXFRBS4KjBpztCS8KrOWS34Al3GeMCYMyGqC7SgtSCkrOgS0S30KvnRO0jOZDFBnxnouiwFNcSxU0NSyfkhc0O27t4gOHWFzlvVRbj-mSu0f3rcb7b57vX5ZbPe5YZR1uQaE2pVowllDJe1LltttanUtDRNUzFDbMW55i0zhlMjjG5sqTBmWFBQlq3Q3Rw7Bv9xhJhk7-LpNDWAP0ZJGoopZmKKWqFylprgYwzQyjG4XoUvSbA8AZIHOQOSJ0ASV3ICNNlufxqOugf7Z_qlMwkeZgFMb346CDIaB4MB6wKYJK13_zd8A5l7eqU</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Bekadja, Mohamed Amine</creator><creator>Brahimi, Mohamed</creator><creator>Osmani, Soufi</creator><creator>Yafour, Nabil</creator><creator>Krim, Amina</creator><creator>Serradj, Faiza</creator><creator>Talhi, Souad</creator><creator>Amani, Kamila</creator><creator>Bouhass, Rachid Amar</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20171201</creationdate><title>Hematopoietic stem cell transplantation in Algeria</title><author>Bekadja, Mohamed Amine ; Brahimi, Mohamed ; Osmani, Soufi ; Yafour, Nabil ; Krim, Amina ; Serradj, Faiza ; Talhi, Souad ; Amani, Kamila ; Bouhass, Rachid Amar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3239-b012da9b1233048b4fbdbc5a2dac9953c1d566b6f3cc62c7cb9d4a003072ead3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bekadja, Mohamed Amine</creatorcontrib><creatorcontrib>Brahimi, Mohamed</creatorcontrib><creatorcontrib>Osmani, Soufi</creatorcontrib><creatorcontrib>Yafour, Nabil</creatorcontrib><creatorcontrib>Krim, Amina</creatorcontrib><creatorcontrib>Serradj, Faiza</creatorcontrib><creatorcontrib>Talhi, Souad</creatorcontrib><creatorcontrib>Amani, Kamila</creatorcontrib><creatorcontrib>Bouhass, Rachid Amar</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hematology/oncology and stem cell therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bekadja, Mohamed Amine</au><au>Brahimi, Mohamed</au><au>Osmani, Soufi</au><au>Yafour, Nabil</au><au>Krim, Amina</au><au>Serradj, Faiza</au><au>Talhi, Souad</au><au>Amani, Kamila</au><au>Bouhass, Rachid Amar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hematopoietic stem cell transplantation in Algeria</atitle><jtitle>Hematology/oncology and stem cell therapy</jtitle><addtitle>Hematol Oncol Stem Cell Ther</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>10</volume><issue>4</issue><spage>311</spage><epage>314</epage><pages>311-314</pages><issn>1658-3876</issn><abstract>Algeria is a country of 40.4 million inhabitants and half of which is under 30years. In Algeria, Health-care insurance covered, 90% of the population. Health care is free and it is supported by the Ministry of Health. 16 university hospitals exist in Algeria and only two (Algiers and Oran) practicing bone marrow transplant. Adult hematologic malignancies account for 10% (about 4000 new cases/year) of the malignancy affecting in most cases young patients under 65years of age. In 2016, 270 transplants were performed in total (Algiers+Oran), including 149 allografts (related donor transplants: 99%) and 121 autografts. 98% of transplants are done in adults and only 2% in children with cord blood transplants. In summary for the two transplant centers, the predominant types of transplantation performed are allogeneic transplant in 55% and autologous transplant in 45%. The particularity of EHU1st November in Oran, is the use of non-cryopreserved stem cells. Stem cell was mobilized using G-CSF alone and the grafts were kept in a conventional blood bank refrigerator at +4°C until reinfusion on day 0. The outcome with non-cryopreserved stem cells are the same as those with cryopreserved stem cells and we conclude that autologous transplant with non cryopreserved hematopoietic stem cells (HSC) is a simple, effective and safe method and the cryopreservation is not necessary in our work conditions in developing countries. The projects are achieving the autograft in all University Hospitals with non cryopreserved HSC, achieving a center allograft in the east of the country and the development of bone marrow transplantation in children. Currently in Algeria, the number of transplantation is insufficient and the development of new transplant centers is essential. In the future, we hope to implement the National Society of Bone Marrow transplant and also the National recipient registry and Donor registry in Algeria.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>28711452</pmid><doi>10.1016/j.hemonc.2017.05.019</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1658-3876
ispartof Hematology/oncology and stem cell therapy, 2017-12, Vol.10 (4), p.311-314
issn 1658-3876
language eng
recordid cdi_proquest_miscellaneous_1920203795
source ScienceDirect - Connect here FIRST to enable access
title Hematopoietic stem cell transplantation in Algeria
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T02%3A55%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hematopoietic%20stem%20cell%20transplantation%20in%20Algeria&rft.jtitle=Hematology/oncology%20and%20stem%20cell%20therapy&rft.au=Bekadja,%20Mohamed%20Amine&rft.date=2017-12-01&rft.volume=10&rft.issue=4&rft.spage=311&rft.epage=314&rft.pages=311-314&rft.issn=1658-3876&rft_id=info:doi/10.1016/j.hemonc.2017.05.019&rft_dat=%3Cproquest_cross%3E1920203795%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3239-b012da9b1233048b4fbdbc5a2dac9953c1d566b6f3cc62c7cb9d4a003072ead3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1920203795&rft_id=info:pmid/28711452&rfr_iscdi=true